1.Safdat, N, Dezfulian, C, Collard, HR, Sain, S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:2184–2193.
2.Rello, J, Ollendorf, DA, Oster, G, et al. VAP Outcome Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115–2121.
3.Melsen, WG, Rovers, MM, Bonten, MJ. Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med 2009;37:2709–2718.
4.Rosenthal, VD, Guzman, S, Migone, O, Crnich, CJ. The attributable cost length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care department in Argentina: a prospective, matched analysis. Am J Infect Control 2003;34:475–480.
5.Higera, F, Rangel-Frausto, MS, Rosenthal, VD, et al. Attributable cost and length of stay for patients with central venous catheter venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hospital Hosp Epidemiol 2007;28:31–35.
6.Sulis, CA, Walkey, AJ, Abadi, Y, Campbell Reardon, C, Joyce-Brady, M. Outcomes of a ventilator-associated pneumonia bundle on rates of ventilator-associated pneumonia and other health care-associated infections in a long-term acute care hospital setting. Am J Infect Control 2014;42:536–538.